ImmunityBio will lay off 16 employees in El Segundo, California, and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.
https://www.biospace.com/job-trends/immunitybio-to-lay-off-16-will-likely-need-additional-capital
IMMUNITYBIO just did another massive lay off and will continue to lay off people to the end of October. The CEO Richard Co-k had said he will closing IMMUNITYBIO in the city of El Segundo and will also affect employees globally and they planning on moving their operations to South Africa and produce ANKTIVA